HEART FAILURE

09.00
10.00

Modérateurs

S. VARNOUS, P. LEPRINCE, R. ISNARD

Heart failure: ESC report

R. ISNARD

Cardiac arrest during the Covid period

X. JOUVEN

Infiltrative cardiomyopathy: when to propose a cardiac transplantation

A. JOBBE-DUVAL

TRANSPLANTATION

10.15
11.15

Modérateurs

S. VARNOUS, G. LEBRETON, A. BOUGLE

Thoracic organ transplantation: 2019 report

R. DORENT

Cardiac graft allocation score at 3 years

R. DORENT

Evaluation of 16 risk score for mortality after cardiac transplantation based on UNOS database

G. COUTANCE

Double lung transplantation in pre-immunized recipient: role of plasma exchange

J. THES

TRANSPLANTATION AND COVID

11.35
12.35

Modérateurs

S. VARNOUS, P. LEPRINCE, R. DORENT

Organ donors and access to organ transplantation management during the Covid pandemic

C. LEGEAI

Impact of Covid pandemic on transplanted patients or awaiting transplantation

- Heart

F. HAZAN

- Kidney

N.ARZOUK

- Liver

F. CONTI

- Lung

E. SAGE

Cardiac transplantation after SARS-Cov2 myocarditis

C. GOEMINNE

12.35

OPENING CEREMONYM.-A. RUDER, E. CORTOT-BOUCHER

HEART TRANSPLANTATION

13.30
14.30

Modérateurs

S. VARNOUS, P. LEPRINCE, A. CHARFEDDINE

Access to cardiac transplantation for MCS patients with the new cardiac graft allocation score

R. DORENT

Modification on the UNOS cardiac graft allocation system: impact on heart transplantation programs and outcome?

M. SLAUGHTER

Allomap in real life

J.-J. VON HUNOLSTEIN

Risk factors for sudden death in cardiac transplanted patients

G. BONNET

HEART TRANSPLANTATION

14.45
15.45

Modérateurs

G. COUTANCE, G. LEBRETON, P. BATTISTELLA

Urgent cardiac transplantation when cardiac surgery fails

L. LECUYER

Indication and results of Photophoresis in cardiac transplanted patients

L. SEBBAG

Humoral rejection score

G. COUTANCE

De novo DSA after cardiac transplantation

E. DESIRE

Clinical case

- Retransplantation after cardiac graft humoral rejection. Interest of tocilizumab and 18 month follow-up

P. BATTISTELLA

HEART TRANSPLANTATION

16.05
17.00

Modérateurs

S. VARNOUS, E. EPAILLY, G. LEBRETON

Cardiac transplantation for Arrhythmogenic right ventricular dysplasia

- Pitié-Salpêtrière Experience

E. GANDJBAKHCH

- Review

B. PERIN

Longitudinal Pulmonary artery pressure assessment in 12 cardiac transplanted patients

P. BATTISTELLA

Pentoglobine and Covid: a nice wedding?

E. EPAILLY

Clinical case

E. DESIRE

Recurrent pericardial effusion after cardiac transplantation

HEART TRANSPLANTATION

17.15
18.00

Modérateurs

S. VARNOUS, G. COUTANCE, P. DEMONDION

CMV and cardiac transplantation: Valganciclovir toxicity

G. COUTANCE, E. DESIRE

Cardiac transplantation for sarcoma

E. EPAILLY

Repeated and multimodal assessment of RV function as a long term prognosis after cardiac transplantation

B. PERIN

PROFESSIONAL DEVELOPMENT FOR NURSES

09.00
10.00

Chairmen

S. VARNOUS, S. BOVAGNET, G. LEBRETON

Thoracic organ transplantation: 2019 report

R. DORENT

Cardiac graft allocation score at 3 years

R. DORENT

Heart transplanted patient rehabilitation

M.-C. ILIOU

10.15
11.05

Chairmen

S. VARNOUS, S. CANIKLI, G. LEBRETON

Specificities of the organization of Heart transplanted patients’ follow-up

S. JAMET, L. COURTINE

Pregnancy and cardiac transplantation

E. HUGON-VALLET

Cardiac transplanted patients association: activity report

O.LECRY, J. CAMUS

11.30
12.30

Chairmen

S VARNOUS, H. OLEON, P. LEPRINCE

Quadritherapy: benefi t/risk

L. NGUYEN

Advanced practice nurse in cardiac transplantation

E. FALCONE-NICOL

Clinical cases

E. DESIRE, L. NGUYEN

OPENING CEREMONY S. SAUVAGE, C. LE CORRE

13.30
14.30

Chairmen

G. COUTANCE, E. CAUDRON DE COQUEREAUMONT, P. LEPRINCE

Impact of the new heart allocation system on transplant coordination organization

E. COCHAT, J. PERRIN

Focus on chronic renal failure after cardiac transplantation

E. VERMES

Focus on infection in heart transplanted patients

G. HEKIMIAN

14.45
15.45

Chairmen

M. NICULESCU, L. GUIDEZ, P. LEPRINCE

COFDAC: new development available for patients and VAD team

V. DESRIAC

Focus on different type of short and long term MCS

G. LEBRETON

End of life for LVAD patients

V. DESRIAC

16.15
17.15

Chairmen

G. LEBRETON, S. RUGARD, E. BOSQ

ECMO Covid Île-de-France

G. LEBRETON

ECMO Covid: perfusionist point of view

E. HIRSCHAUER

Nurse management of ECMO canula

A. PEUCH

Clinical case

P. DEMONDION

ECMO

08.30
09.30

Chairmen

G. LEBRETON, A. COMBES, A. BOUGLE

ECMO Covid Sorbonne University

M. SCHMIDT

ECMO Covid Île-de-France

G. LEBRETON

Focus on several organization for ECMO mobile unit

G. LEBRETON

E. FLECHER

ECMO

09.45
10.45

Chairmen

P. LEPRINCE, M. SCHMIDT

Cardiogenic shock: new classifi cation highlighting clinical trial

A. MEBAZAA

ECMO, Cytosorb en cytokines in Covid patients

G. GOROCHOV

ECMO: etiology related outcome

P. DANIAL

ECMO

11.05
12.00

Chairmen

G. LEBRETON, E. FLECHER, A. CHARFEDDINE

Clinical deterioration on the waiting list: risk and benefi t of ECMO

G. COUTANCE

ECMO pre LVAD

B. LEVY

From ECMO to Excor BIVAD: Barcelona Experience

A. MIRALLES-CASSINA

LVAD implantation through mini-thoracotomy decrease the risk of RV failure

M. KINDO

ECMO

12.15
13.00

Chairmen

P. LEPRINCE, A. VINCENTELLI, G. LEBRETON

Fast recovery after cardiac surgery program applied to cardiac transplantation and LVAD implantation

M. KINDO

LVAD: earlier implantation for a better outcome: which strategy for intermacs 4-7?

G. BAUDRY

13.45
14.50

Chairmen

P. LEPRINCE, M. KINDO, M. NICULESCU

Right ventricular function assessment before LVAD implantation

M. YUZEFPOLSKAYA

Optimal timing to implant ECMO patients with a TAH syncardia

M. CARRIER

LVAD drive line exit: improved management

A. BERNHARDT

LVAD and ICD: for who, when, which device and programmation?

V. GALAND

MECHANICAL CIRCULATORY SUPPORT

15.00
16.00

Chairmen

P. LEPRINCE, G. LEBRETON

Industrial update

- Abiomed

J. FLECHE

- Update

P. JANSEN

- CorWave Update

C. RASSER